Soy Isoflavones powder products are our daily food. Soya contains many phytochemicals. In particular, soy isoflavones. Due to its estrogenic and non-hormonal nature, it can have an effect through a variety of mechanisms. It is beneficial for fertility. And look at its mechanisms.

What Is Soy Isoflavones?
Soy Isoflavones powder products are non-steroidal compounds. Their chemical structure is similar to that of endogenous estrogens, which are called phytoestrogens. Soya is almost the only source of isoflavones in the human diet. Isoflavones have a variety of biological properties. It acts as a selective tissue estrogenic activity regulator (STEAR). In addition, isoflavones act as selective estrogen receptor modulators (SERMs) with agonistic and antagonistic effects on estrogen receptors. This subsequently produces estrogenic, anti-estrogenic, and even neutral effects. In addition, it has antioxidant activity. By this mechanism, soy is linked to female fertility. So, what is the specific impact of soy, soy foods, and soy components (especially isoflavones) intake on female fertility?
Soy Isoflavones and Fertility
In a 2005 Japanese study, 36 women with secondary amenorrhoea (or anovulation) were given 6 grams of black soybean powder daily. Eventually, 4 patients became pregnant and 12 had improved ovulation. 6 months later, the patients' oestradiol levels were higher than those of the control group, while luteinizing hormone (LH) and follicle-stimulating hormone (FSH) remained unchanged. Black beans, which are consumed relatively little in this country, are rich in antioxidant substances in addition to isoflavones, especially the anthocyanin-rich outer skin.
These substances may play a role in the function of the ovarian circulation. Exactly which substances play a role is not clear. Since then, there have been longitudinal cohort observational studies in both the United States and Canada, and from the data obtained, dietary isoflavones do not seem to have a direct effect on fertility, either positively or negatively.
Effect on menstrual cycle length in healthy women
In a study in the United States, six women aged 22-29 years were given soya milk for 1 month (1 liter/day in 3 doses. This corresponds to a total daily intake of about 200mg of isoflavone bulk powder). The length of the menstrual cycle increased slightly (from 28.3 ± 1.9 to 31.8 ± 5.1 days). A prospective cohort study of 246 US women with a 10 mg/d increase in dietary isoflavones showed a slight decrease in the luteal phase.
In a prospective study, 326 women aged 18-40 years were followed for 12 months or until pregnancy. The authors found that cycle length (detected by fertility monitoring and daily journals) was negatively correlated with total urinary phytoestrogen levels. However, the detection of phytoestrogens from other sources affected the interpretation of the results. Luteal phase defects were associated with pregnancy outcomes and fertility disorders. However, the association between soy and isoflavones and reduced luteal phase appeared to be weak. The possible correlation between menstrual cycle length and soy also seems unconvincing. Overall, the effect of soy and its components on the menstrual cycle in healthy women appears to be unclear.
Hormonal status in healthy women
In the US study described earlier, a daily intake of 1 liter of soya milk for 1 month resulted in a 31% reduction in mean oestradiol levels on days 5-7 of menstruation. It was 81 per cent on days 12-14. It was 49 percent on days 20-22. This effect lasted for at least one menstrual cycle and up to three menstrual cycles after stopping soy consumption compared to baseline. In addition, the reduction in luteal phase progesterone levels was also significant with soy intake, averaging 35%. Soy also led to a significant reduction in dehydroepiandrosterone sulfate (DHEAS) levels by 23%. there were no significant changes in LH and FSH levels. In a study of soy Isoflavones powder (37.4 g of soy protein), premenopausal women had elevated levels of oestradiol in both the luteal and follicular phases. Progesterone and SHBG concentrations did not change. a study of 50 Japanese women showed a negative correlation between oestradiol and soy intake in the mid-luteal phase.

Polycystic ovary syndrome
In an Italian study, no clinical improvement, menstrual cycle changes, or hormonal changes (estradiol, SHBG, DHEAS, androstenedione, testosterone, FSH, LH) were observed. Improvements were observed only in lipid profile (circulating total cholesterol, LDL and LDL/HDL ratios, and triglycerides). In a parallel clinical trial of 137 Iranian women with PCOS, reductions in LH levels (-9.4%), testosterone (-5.6%,) and DHEAS (-8.7%). It also reduced LDL and triglyceride levels. Another parallel clinical trial in Iran using 50 mg/d of soy isoflavones was followed up for 1 month. The intervention reduced the free androgen index and total testosterone. There was no significant difference in free testosterone and DHEAS. Improved hormone levels were followed by improved clinical symptoms in the intervention group. such as reduced hair loss, serum insulin levels, HOMA-B, and HOMA-IR indices. In a longitudinal case-control clinical trial in Australia, 400 ml of soya milk (containing approximately 50 mg of isoflavones) was used daily. Across the cohort, reductions in estrogen levels were associated with reductions in androgen levels (total testosterone, free testosterone, and androstenedione). Glucose homeostasis was improved. Overall, soy tends to improve in patients with PCOS.
Effects on the IVF population
For 134 women who had been infertile for at least 2 years, 1500 mg of soy Isoflavones powder or placebo was given daily. These women were intrauterine inseminated 5 days after taking clomiphene. Although FSH, LH, and oestradiol were significantly increased in both intervention groups. However, there was a significant improvement in endometrial thickness (assessed by transvaginal ultrasound) in the intervention group compared to placebo. In addition, the intervention groups had lower miscarriage rates and higher pregnancy rates. There were no differences in follicular development, pre-ovulatory follicle number, and pulsatility index between the intervention groups. It is hypothesized that treatment with pharmacological concentrations of soy phytoestrogens may attenuate the negative effects of clomiphene on endometrial tissue, thereby promoting embryo implantation. The investigators used the same type of soy phytoestrogen intervention in a second clinical trial. They tested 213 infertile women undergoing IVF. These infertile women received embryo transfer after intramuscular progesterone (50 mg/d) and ingestion of 1500 mg/d of isoflavone soy powder. Concomitant treatment with soy phytoestrogens significantly increased the rate of implantation (25.4 % vs 20.2 %), pregnancy (39.3 % vs 20.9 %), and carryover (30.3 % vs 16.2 %) compared to the placebo group. There were no significant differences in spontaneous abortion rates, the number and quality of embryos.
Concerning the two studies mentioned above, it is worth noting that the amount of isoflavones used was very high. This is because it is not possible to obtain such doses through diet. Therefore the effects found can be explained as pharmacological rather than simple nutritional intervention. Results of a study of 315 American women, who underwent 530 cycles of assisted reproductive technology. Significant correlations were found between dietary soy intake and fertilization rates (77% vs 71%), pregnancy rates (52% vs 41%), and live birth rates (44% vs 31%) compared to controls. Another prospective cohort study of 239 patients undergoing ART found a protective effect of higher soy intake (mean isoflavone intake of 3⋅4 mg/d) against bisphenol A (BPA)-induced fertility disorders.
Therefore, from the available data obtained, soy and isoflavones may have beneficial effects on fertility. Especially for those with fertility problems. However, as mentioned in the previous paragraphs, it may have a neutral effect, i.e. no particular benefit or detriment, in normally fertile individuals. Soy Isoflavones powder products are used in a wide range of applications in the food industry. If you are interested in our products, welcome to inquiry us: info@gybioteh.com.






